Substance · official US FDA label
Bétaméthasone (betamethasone)
47 medicines listed on Vimpia contain it, alone or combined. Below, the official US FDA label for betamethasone, unchanged.
Want to buy it?
Trouver shows the pharmacies near you that have it right now, and their prices. The reservation pages are in French.
This is a US label.
The official US FDA label for betamethasone (published as BETAMETHASONE DIPROPIONATE), effective August 31, 2026, describes products sold in the United States. The medicine sold in DR Congo may differ in strength, form or approved uses: ask a pharmacist or a doctor.
Official US FDA label for betamethasone
Data provided by the U.S. Food and Drug Administration (openFDA), unchanged. The full label on DailyMed.
Uses
INDICATIONS AND USAGE: Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Dosage
US dosage, for products sold in the United States. For a medicine bought in DR Congo, follow its box, its leaflet or your pharmacist.
DOSAGE AND ADMINISTRATION: Apply a thin film of Betamethasone Dipropionate Cream or Ointment to the affected skin areas once daily. In some cases, twice daily dosage may be necessary. Apply a few drops of Betamethasone Dipropionate Lotion to the affected skin areas and massage lightly until it disappears. Apply twice daily, in the morning and at night. If an infection develops, appropriate antimicrobial therapy should be instituted. Betamethasone Dipropionate products should not be used with occlusive dressings.
Side effects
ADVERSE REACTIONS: The following local adverse reactions are reported infrequently when Betamethasone Dipropionate products are used as recommended in the DOSAGE AND ADMINISTRATION section. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infections, skin atrophy, striae and miliaria. Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia and glucosuria in some patients.
Medicines that contain it
Names as they are sold. A medicine without an English page links to its French page.
- BETAMETHASONE ARROW 0,05 %, solution buvable en gouttes
- BETAMETHASONE ARROW 2 mg, comprimé dispersible sécable
- BETAMETHASONE BIOGARAN 0,05 %, crème
- BETAMETHASONE BIOGARAN 0,05 %, solution buvable en gouttes
- BETAMETHASONE BIOGARAN 2 mg, comprimé dispersible sécable
- BETAMETHASONE EG 0,05 POUR CENT, solution buvable en gouttes
- BETAMETHASONE EG 2 mg, comprimé dispersible sécable
- BETAMETHASONE ZENTIVA 0,05 %, solution buvable en gouttes
- BETAMETHASONE ZENTIVA 2 mg, comprimé dispersible sécable
- Betastene 0.05%, solution orale gtte
- BETESIL 2,250 mg, emplâtre médicamenteux
- BETNESOL 0,50 mg, comprimé effervescent
- BETNESOL 4 mg/1 ml, solution injectable
- BETNEVAL 0,1 %, crème
- BETNEVAL 0,1 %, pommade
- BETNEVAL LOTION 0,1 %, émulsion pour application cutanée
- BUCCOBET 0,1 mg, comprimé à sucer
- Bétaméthasone 0,1%, Crème
- Bétaméthasone 0,1%, Pommade
- Bétaméthasone 0,10%, Pommade
- Celestene 0,0005, solution orale gtte
- CELESTENE 0,05 POUR CENT, solution buvable en gouttes
- CELESTENE 2 mg, comprimé dispersible sécable
- CELESTENE 4 mg/1 ml, solution injectable
- CELESTENE CHRONODOSE 5,70 mg/ml, suspension injectable
- DIPROLENE 0,05 %, pommade
- DIPROSALIC, lotion
- DIPROSONE 0,05 %, crème
- DIPROSONE 0,05 %, lotion
- DIPROSONE 0,05 %, pommade
- DIPROSTENE, suspension injectable en seringue pré-remplie
- Antol 1% p/p /0.05% v/v /1% p/p, crème topique (in French)
Combined with other substances
- Bactilief 1,00 % (p/p)/ 0,05 %(p/p)/ 0,5 (p/p), crème topique (in French)
Combined with other substances
- CALCIPOTRIOL/BETAMETHASONE SANDOZ 50 microgrammes/0,5 mg/g, pommade (in French)
Combined with other substances
- CLOSALIS 50 microgrammes/0,5 mg/g, gel (in French)
Combined with other substances
- CLOSALIS 50 microgrammes/0,5 mg/g, pommade (in French)
Combined with other substances
- DAIVOBET 50 microgrammes/0,5 mg/g, gel (in French)
Combined with other substances
- DAIVOBET 50 microgrammes/0,5 mg/g, pommade (in French)
Combined with other substances
- Delabact 1.0% p/p 0.05% p/P 0.5% p/p, crème (in French)
Combined with other substances
- DERMAFUSONE 20 mg/1 mg/g, crème (in French)
Combined with other substances
- Dermazema 1 mg/ 10 mg / 0,5 mg, crème topique (in French)
Combined with other substances
- ENSTILAR 50 microgrammes/0,5 mg/g, mousse cutanée (in French)
Combined with other substances
- Funbact-A 1.0% p/p 0.05% p/P 0.5% p/p / 0.1% p/p, crème topique (in French)
Combined with other substances
- Labenda 0,64 mg/10 mg/ 1 mg, crème (in French)
Combined with other substances
- Tridox 0.5 mg/ 10 mg/ 1 mg, crème (in French)
Combined with other substances
- XAMIOL 50 microgrammes/0,5 mg/g, gel (in French)
Combined with other substances
- Xentol 1%p/p/0,05%/0,05%p/p, crème topique (in French)
Combined with other substances
Sources
- ●Labels: U.S. Food and Drug Administration, openFDA (public domain). Data provided by the U.S. Food and Drug Administration (openFDA), unchanged. DailyMed.
- ●English names of substances: RxNorm, U.S. National Library of Medicine.
- ●Marketing authorizations: register of the ACOREP, DR Congo.
- ●Essential medicines: national list of essential medicines of DR Congo (LNME).
- ●Composition: public medicines database of France (BDPM), ANSM, open licence.
Public information, for reference only: it does not replace the advice of a pharmacist or a doctor. Vimpia writes nothing about how to use a medicine and translates nothing: the label is the US FDA's, unchanged; names, composition and authorizations come from the official sources above.